Outcomes for Nitazoxanide Treatment in a Case Series of Patients with Primary Immunodeficiencies and Rubella Virus Associated Granuloma

PURPOSE: Nitazoxanide was recently reported as having in vitro effectiveness against the rubella virus. Immunodeficiency-related vaccine-derived rubella occurs in some patients who have an inherited immunodeficiency and who received the MMR vaccine. This study investigated the in vivo effectiveness...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Immunol
Asıl Yazarlar: Perelygina, Ludmila, Buchbinder, David, Dorsey, Morna J., Eloit, Marc, Hauck, Fabian, Hautala, Timo, Moshous, Despina, Uriarte, Ignacio, Deripapa, Elena, Icenogle, Joseph, Sullivan, Kathleen E
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6383808/
https://ncbi.nlm.nih.gov/pubmed/30680653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-019-0589-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller